U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07084948) titled 'Using Flavonoids to Kill Hepatitis B Virus' on July 03.
Brief Summary: The composition treats Acute Hepatitis, Chronic Hepatitis, Cirrhosis, and hepatocellular carcinoma (S.B.Flavonoids) at an early stage. The product is Acid ascorbic, L-Arginine hydrochloride, Kaempferol, Urinariaflavone, 5,6-dihydroxy-7,8,4'-trimethoxy-flavone, Quercetin, Rutin.
These components have participated in to protect liver cell membranes, focus on reducing liver stress and supporting their structure repairing and regenerating new liver parenchyma, preventing fibrosis cell generation, and preventing liver cancer cell growth at an early stage. The composi...